You might want to take a look at Surgery Partners Inc (SGRY) now

With 0.74 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.93 million shares. The 52-week range on SGRY shows that it touched its highest point at $45.79 and its lowest point at $22.05 during that stretch. It currently has a 1-year price target of $43.00. Beta for the stock currently stands at 2.71.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SGRY was up-trending over the past week, with a rise of 5.52%, but this was down by -4.33% over a month. Three-month performance dropped to -7.73% while six-month performance rose 5.41%. The stock lost -4.88% in the past year, while it has lost -6.75% so far this year. A look at the trailing 12-month EPS for SGRY yields -0.10 with Next year EPS estimates of 1.28. For the next quarter, that number is 0.08. This implies an EPS growth rate of -0.40% for this year and 28.45% for next year. EPS is expected to grow by 45.50% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 54.69%.

Float and Shares Shorts:

At present, 126.59 million SGRY shares are outstanding with a float of 73.01 million shares on hand for trading. On Mar 15, 2024, short shares totaled 8.04 million, which was 6.35% higher than short shares on Feb 15, 2024. In addition to Mr. Wayne Scott DeVeydt as the firm’s Executive Chairman, Mr. J. Eric Evans serves as its CEO & Director.

Institutional Ownership:

Through their ownership of 107.62% of SGRY’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SGRY since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, SGRY has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and SGRY currently yields $0.00. In the past year, SGRY’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, SGRY has a current buyback yield of $0.00. This was $0.00 for the TTM, and it was $– for the past five years.